Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 3
2001 5
2002 1
2003 8
2004 14
2005 9
2006 6
2007 6
2008 7
2009 6
2010 4
2011 4
2012 4
2013 4
2014 3
2015 4
2016 1
2017 2
2021 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

79 results

Results by year

Filters applied: . Clear all
Page 1
AGA Clinical Practice Update: Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Lean Individuals: Expert Review.
Long MT, Noureddin M, Lim JK. Long MT, et al. Gastroenterology. 2022 Sep;163(3):764-774.e1. doi: 10.1053/j.gastro.2022.06.023. Epub 2022 Jul 14. Gastroenterology. 2022. PMID: 35842345 Free PMC article.
BEST PRACTICE ADVICE 7: In patients with lean NAFLD, other causes of liver disease should be ruled out, including other causes of fatty liver, such as HIV, lipodystrophy, lysosomal acid lipase deficiency, familial hypobetalipoproteinemia, and medication-induced hepa …
BEST PRACTICE ADVICE 7: In patients with lean NAFLD, other causes of liver disease should be ruled out, including other causes of fatty live …
Metreleptin treatment of non-HIV lipodystrophy syndromes.
Chevalier B, Lemaitre M, Leguier L, Mapihan KL, Douillard C, Jannin A, Espiard S, Vantyghem MC. Chevalier B, et al. Presse Med. 2021 Nov;50(3):104070. doi: 10.1016/j.lpm.2021.104070. Epub 2021 Sep 24. Presse Med. 2021. PMID: 34571177 Review.
Pathophysiology of dyslipidemia and increased cardiovascular risk in HIV lipodystrophy: a model of 'systemic steatosis'.
Balasubramanyam A, Sekhar RV, Jahoor F, Jones PH, Pownall HJ. Balasubramanyam A, et al. Curr Opin Lipidol. 2004 Feb;15(1):59-67. doi: 10.1097/00041433-200402000-00011. Curr Opin Lipidol. 2004. PMID: 15166810 Review.
Identification of rationally based therapies requires an understanding of the mechanistic basis of HADL. RECENT FINDINGS: A case definition for HIV lipodystrophy, based on age, gender, duration of HIV disease, serum HDL cholesterol and anthropometry, provides high d …
Identification of rationally based therapies requires an understanding of the mechanistic basis of HADL. RECENT FINDINGS: A case definition …
Pathophysiology of GHRH-growth hormone-IGF1 axis in HIV/AIDS.
Jain S, Desai N, Bhangoo A. Jain S, et al. Rev Endocr Metab Disord. 2013 Jun;14(2):113-8. doi: 10.1007/s11154-013-9245-9. Rev Endocr Metab Disord. 2013. PMID: 23657561 Review.
One is primarly associated with development of lipodystrophy and results in complications such as chronic inflammation, insulin resistance, lipid and metabolic abnormalities. HIV lipodystrophy is found especially in those on highly active anti-retroviral therapy (HA …
One is primarly associated with development of lipodystrophy and results in complications such as chronic inflammation, insulin resistance, …
Plastic surgical options for HIV-associated lipodystrophy.
Nelson L, Stewart KJ. Nelson L, et al. J Plast Reconstr Aesthet Surg. 2008;61(4):359-65. doi: 10.1016/j.bjps.2007.11.014. Epub 2007 Dec 21. J Plast Reconstr Aesthet Surg. 2008. PMID: 18155655 Review.
Based on a literature search conducted using OVID Medline, this review shall describe the various treatment options employed by plastic surgeons to deal with the problems of fat distribution in patients suffering from HIV-lipodystrophy, and examine the evidence for …
Based on a literature search conducted using OVID Medline, this review shall describe the various treatment options employed by plastic surg …
HIV-associated lipodystrophy: pathogenesis, prognosis, treatment, and controversies.
Koutkia P, Grinspoon S. Koutkia P, et al. Annu Rev Med. 2004;55:303-17. doi: 10.1146/annurev.med.55.091902.104412. Annu Rev Med. 2004. PMID: 14746523 Review.
Unfortunately, highly active antiretroviral therapy is often compromised by metabolic complications, including insulin resistance, dyslipidemia, and fat redistribution. Together these changes have been termed the HIV-lipodystrophy syndrome, which is estimated to aff …
Unfortunately, highly active antiretroviral therapy is often compromised by metabolic complications, including insulin resistance, dyslipide …
HIV lipodystrophy: risk factors, pathogenesis, diagnosis and management.
Carr A. Carr A. AIDS. 2003 Apr;17 Suppl 1:S141-8. AIDS. 2003. PMID: 12870540 Review.
HIV lipodystrophy is a heterogeneous syndrome, which has yet to be objectively defined, comprising peripheral lipoatrophy, central fat accumulation and lipomata, along with hyperlipidaemia, insulin resistance and lactic acidaemia. ...
HIV lipodystrophy is a heterogeneous syndrome, which has yet to be objectively defined, comprising peripheral lipoatrophy, cen …
Pharmacologic therapy for HIV-associated lipodystrophy.
Benavides S, Nahata MC. Benavides S, et al. Ann Pharmacother. 2004 Mar;38(3):448-57. doi: 10.1345/aph.1D081. Epub 2004 Jan 30. Ann Pharmacother. 2004. PMID: 14755064 Review.
DATA SYNTHESIS: Lipodystrophy has become more prevalent in patients with HIV. Lipodystrophy consists of adipose redistribution and metabolic abnormalities including dyslipidemia and insulin resistance. ...
DATA SYNTHESIS: Lipodystrophy has become more prevalent in patients with HIV. Lipodystrophy consists of adipose redistribution …
HIV lipodystrophy syndrome: a primer.
Robinson FP. Robinson FP. J Assoc Nurses AIDS Care. 2004 Jan-Feb;15(1):15-29. doi: 10.1177/1055329003255117. J Assoc Nurses AIDS Care. 2004. PMID: 14983558 Review.
Treatment with highly active antiretroviral therapy (HAART) has been implicated in the development of anthropomorphic and metabolic abnormalities termed HIV lipodystrophy syndrome (or LDS). This primer offers a comprehensive overview of LDS including epidemiology, h …
Treatment with highly active antiretroviral therapy (HAART) has been implicated in the development of anthropomorphic and metabolic abnormal …
79 results